Explore Diverse Perspectives.
Published loading...Updated

Why Requiring Placebo-Controlled Trials For New Vaccines Could Harm Americans

  • The U.S. Department of Health and Human Services will require placebo-controlled trials for all new vaccines before approval, affecting vaccines like COVID-19 updates.
  • This policy arose amid concerns over vaccine safety transparency, although none of the existing childhood vaccines except COVID-19 were tested against inert placebos.
  • Experts warn the mandate could delay vaccine availability since placebo trials are lengthy and ethically complex, especially when vaccines have known safety profiles and emergency use precedents exist.
  • Dr. Jesse Goodman, former FDA vaccine chief, expressed concern that requiring clinical trials for each strain change would lead to continuous testing and prevent vaccines from staying current.
  • The requirement risks slowing access to life-saving vaccines during outbreaks and could worsen public health outcomes by discouraging timely updates and fueling vaccine skepticism.
Insights by Ground AI
Does this summary seem wrong?

29 Articles

All
Left
5
Center
5
Right
4
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 36% of the sources lean Left, 36% of the sources are Center
36% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

BBC News broke the news in United Kingdom on Thursday, May 1, 2025.
Sources are mostly out of (0)